Cecropin-B

General Information


DRACP ID  DRACP00389

Peptide Name   Cecropin-B

Sequence  KWKIFKKIEKVGRNIRNGIIKAGPAVAVLGEAKAL

Sequence Length  35

UniProt ID  P01509 

PubChem CID  Not available

Origin  Antheraea pernyi (Chinese oak silk moth)

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
RAW 264.7 Mouse macrophage leukemia cell Leukemia Not active up to 100 µM CCK-8 assay 1 day 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00389

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C177H303N51O42

Absent amino acids  CDHMQSTY

Common amino acids  K

Mass  442433

Pl  11.49

Basic residues  9

Acidic residues  2

Hydrophobic residues  17

Net charge  7

Boman Index  -3091

Hydrophobicity  0.29

Aliphatic Index  117.14

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  161.76

Polar residues  6

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30065898

Title  A novel cecropin B-derived peptide with antibacterial and potential anti-inflammatory properties

Doi 10.7717/peerj.5369

Year  2018

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_572

DRACP is developed by Dr.Zheng's team.